These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20367558)

  • 1. Determinants of the release pattern of ischaemia-modified albumin in acute ST-elevation myocardial infarction treated with primary PCI.
    Hjortshøj S; Dethlefsen C; Kristensen SR; Ravkilde J
    Scand J Clin Lab Invest; 2010 Jul; 70(4):244-51. PubMed ID: 20367558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia.
    Hjortshøj S; Dethlefsen C; Kristensen SR; Ravkilde J
    Clin Chim Acta; 2009 May; 403(1-2):114-20. PubMed ID: 19361451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
    Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
    Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty?
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Jimenez-Sosa A; Samimi-Fard S; Idaira HB
    Biomarkers; 2009 Feb; 14(1):43-8. PubMed ID: 19283523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Samimi-Fard S; Kaski JC
    Clin Chim Acta; 2008 Feb; 388(1-2):196-9. PubMed ID: 18036561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemia-modified albumin elevation after percutaneous coronary intervention reflects albumin concentration rather than ischaemia.
    Demir H; Topkaya BC; Erbay AR; Dogan M; Yücel D
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):327-31. PubMed ID: 19487408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.
    Hjortshøj S; Kristensen SR; Ravkilde J
    Am J Emerg Med; 2010 Feb; 28(2):170-6. PubMed ID: 20159386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction.
    McGehee JT; Rangasetty UC; Atar S; Barbagelata NN; Uretsky BF; Birnbaum Y
    J Electrocardiol; 2007 Jan; 40(1):26-33. PubMed ID: 17067628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.
    Roy D; Quiles J; Aldama G; Sinha M; Avanzas P; Arroyo-Espliguero R; Gaze D; Collinson P; Carlos Kaski J
    Int J Cardiol; 2004 Nov; 97(2):297-301. PubMed ID: 15458698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of T-wave amplitude and dynamics at the time of reperfusion in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Sørensen JT; Murinson MA; Kaltoft AK; Nikus KC; Wagner GS; Terkelsen CJ
    J Electrocardiol; 2009; 42(6):677-83. PubMed ID: 19595361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
    Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
    Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
    Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I.
    Sygitowicz G; Janas J; Białek S; Pręgowski J; Pera L; Sitkiewicz D
    Scand J Clin Lab Invest; 2013 Mar; 73(2):130-4. PubMed ID: 23327102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.